Partners Os Ltd. Bvf serves as Executive at Xenon Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Partners Os Ltd. Bvf has executed 52 insider transactions totaling $36.7M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 5, 2017 involved purchasing 12,624 shares valued at $28.9K.
Partners Os Ltd. Bvf currently holds 555,105 shares of Xenon Pharmaceuticals Inc. (XENE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Partners Os Ltd. Bvf has been a net buyer of XENE stock. They have purchased $36.4M and sold $225.0K worth of shares.
Partners Os Ltd. Bvf's most recent insider trade was on Jun 5, 2017, when they purchased 12,624 shares at $2.29 per share.
Get notified when new Form 4 filings are submitted
| $2.29 |
| Discretionary |